The PREVENTS Trial: The Preventing Recurrent Events in Veterans Navigating Transient Ischemic Attack (TIA) or Stroke Trial
NCT01020851 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 202
Last updated 2015-04-15
Summary
National recommendations state that patients with a history of transient ischemic attack (TIA) or ischemic stroke should receive hypertension treatment, including antihypertensive medication and lifestyle modification, with a goal of reducing blood pressure (BP) to \<120 mm Hg systolic BP and \<80 mm Hg diastolic BP. Statin treatment and lifestyle modification is also recommended for post-stroke and post-TIA patients with elevated cholesterol levels or a history of stroke or TIA with an atherosclerotic cause. Despite the clear benefits of secondary stroke prevention, there is a gap between evidence and implementation in clinical practice. By a randomized controlled trial, the investigators will test whether a tailored, telephone-delivered transtheoretical model-based behavioral intervention will improve adherence to treatment in veterans with a history of TIA or stroke, thereby leading to better control of BP and cholesterol levels, as compared to an attention placebo.
The primary specific aims of this project are to:
* determine whether a behaviorally tailored intervention (TI) can effectively lower BP after 6 months of counseling as compared to an attention placebo (AP) in veterans with a history of stroke or TIA
* assess whether the TI is effective in improving adherence to diet after 6 months of counseling in veterans with a history of stroke or TIA.
Secondary aims are to
* assess whether the TI is effective in improving cholesterol levels in post-stroke veterans after 6 months
* evaluate whether the TI is effective in improving adherence to antihypertensive and lipid-lowering medications after 6 months of counseling in veterans with a history of stroke or TIA
* determine whether the TI is effective in improving adherence to exercise recommendations after 6 months.
To answer this, veterans (n=190) with a history of stroke or TIA will be randomized equally to the TI, which will use the transtheoretical framework to provide 6 monthly counseling phone sessions about adherence to diet, medication, and exercise recommendations, and the AP, in which 6 monthly counseling phone sessions about non-stroke-related health topics will be provided. Participants will make in-person visits at baseline and 6 months. BP (3 measures taken at least 5 min apart) and dietary sodium are the primary outcomes, while secondary outcomes will be total cholesterol/high density lipoprotein ratio, adherence to antihypertensive and lipid-lowering drugs, and exercise adherence.
Conditions
- Stroke
- Transient Ischemic Attack
Interventions
- BEHAVIORAL
-
tailored intervention
6 monthly telephone calls focusing on diet, medication and exercise adherence using the framework of the transtheoretical model
- BEHAVIORAL
-
attention placebo
6 monthly telephone-delivered sessions focusing on general health topics
Sponsors & Collaborators
-
Narrows Institute for Biomedical Research
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-09-30
- Primary Completion
- 2014-09-30
- Completion
- 2014-09-30
Countries
- United States
Study Locations
More Related Trials
-
A Randomized Controlled Trial of TNK-tPA Versus Standard of Care for Minor Ischemic Stroke With Proven Occlusion
NCT02398656 ·Status: COMPLETED ·Phase: PHASE3
-
China Antihypertensive Trial in Acute Ischemic Stroke II
NCT03479554 ·Status: COMPLETED ·Phase: PHASE3
-
Statins in Frail Older Patients with Ischemic Stroke or Transient Ischemic Attack - the Prospective Cohort Study
NCT06785740 ·Status: RECRUITING
-
Intravenous Thrombosis and Patients with Prior Ischemic Stroke Within 3 Months
NCT06841978 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT)
NCT06548971 ·Status: RECRUITING ·Phase: PHASE3
-
Precision Antiplatelet Therapy Guided by Platelet Aggregation Function in Patients With Acute Ischemic STROKE
NCT06853535 ·Status: RECRUITING ·Phase: PHASE3
-
A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel
NCT03766581 ·Status: COMPLETED ·Phase: PHASE2
-
Tenecteplase in Stroke Patients Between 4.5 and 24 Hours
NCT03785678 ·Status: COMPLETED ·Phase: PHASE3
-
Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients (3T Stroke-II)
NCT05281549 ·Status: UNKNOWN ·Phase: PHASE2
-
This Study Uses the SITS Registry to Find Out When Patients With a Heart Rhythm Disorder (Atrial Fibrillation) Start Treatment With Dabigatran After They Had a Stroke
NCT03258645 ·Status: COMPLETED
-
TNK-tPA Evaluation for Minor Ischemic Stroke With Proven Occlusion
NCT01654445 ·Status: COMPLETED ·Phase: PHASE2
-
Combination of Antiplatelet and Anticoagulation for AIS Patients Witn Concomitant NVAF and Extracranial/Intracranial Artery Stenosis
NCT06058130 ·Status: RECRUITING ·Phase: NA
-
Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients (3T Stroke-Ⅲ)
NCT05745259 ·Status: UNKNOWN ·Phase: PHASE3
-
Telestroke for Comprehensive Transient Ischemic Attack Care in Acute Stroke Ready Hospitals
NCT03724110 ·Status: COMPLETED
-
Pre-stroke Cognitive Status and Thrombolytic Therapy
NCT01713491 ·Status: COMPLETED
-
Endovascular Therapy for Acute Ischemic Stroke Trial
NCT02350283 ·Status: COMPLETED ·Phase: PHASE3
-
Tenecteplase Versus Alteplase in Ischemic Stroke Management (TALISMAN)
NCT02180204 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Tenecteplase Versus Alteplase Before Endovascular Therapy for Ischemic Stroke
NCT02388061 ·Status: COMPLETED ·Phase: PHASE2
-
TIMING of Oral Anticoagulant Therapy in Acute Ischemic Stroke With Atrial Fibrillation
NCT02961348 ·Status: COMPLETED ·Phase: NA
-
Teneteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-III
NCT05141305 ·Status: COMPLETED ·Phase: PHASE3
-
Wake up Symptomatic Stroke - Benefit of Intravenous Clot Busters or Endovascular Intervention
NCT01455935 ·Status: UNKNOWN ·Phase: PHASE2
-
Trial of a Secondary Stroke Prevention Program
NCT01071408 ·Status: COMPLETED ·Phase: NA
-
StAtins in Frail OldEr Patients with Ischemic Stroke or Transient Ischemic Attack - the Randomized Controlled Trial
NCT06785727 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Beta Blockers In Acute Ischemic Stroke
NCT01061190 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Intravenous rhTNK-tPA Before Stroke Thrombectomy in the Extended Time Window
NCT06987305 ·Status: RECRUITING ·Phase: PHASE3